Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)
Status:
Completed
Trial end date:
2018-05-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of selonsertib
(GS-4997) in combination with prednisolone versus prednisolone alone in participants with
severe alcoholic hepatitis (AH).